Rapid cloning of antigen-specific T-cell receptors by leveraging the cis activation of T cells

Nat Biomed Eng. 2022 Jul;6(7):806-818. doi: 10.1038/s41551-022-00874-6. Epub 2022 Apr 7.

Abstract

It is commonly understood that T cells are activated via trans interactions between antigen-specific T-cell receptors (TCRs) and antigenic peptides presented on major histocompatibility complex (MHC) molecules on antigen-presenting cells. By analysing a large number of T cells at the single-cell level on a microwell array, we show that T-cell activation can occur via cis interactions (where TCRs on the T cell interact with the antigenic peptides presented on MHC class-I molecules on the same cell), and that such cis activation can be used to detect antigen-specific T cells and clone their TCR within 4 d. We used the detection-and-cloning system to clone a tumour-antigen-specific TCR from peripheral blood mononuclear cells of healthy donors. TCR cloning by leveraging the cis activation of T cells may facilitate the development of TCR-engineered T cells for cancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm
  • Cloning, Molecular
  • Leukocytes, Mononuclear*
  • Peptides
  • Receptors, Antigen, T-Cell / genetics
  • T-Lymphocytes*

Substances

  • Antigens, Neoplasm
  • Peptides
  • Receptors, Antigen, T-Cell